Inscription Capital »

Cullinan Oncology shares owned by Inscription Capital

Quarter-by-quarter ownership of Cullinan Oncology (CGEM) shares owned by Inscription Capital from 13F filings

Historical chart of Inscription Capital investment in Cullinan Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cullinan Oncology held by Inscription Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cullinan Oncology by Inscription Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $67k 11k 5.93

More positions owned by Inscription Capital

Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Spdr Series Trust Bloomberg 1-3 Mo (BIL)
Pgim Etf Tr Pgim Ultra Sh Bd (PULS)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Nike CL B (NKE)
Pgim Etf Tr Aaa Clo Etf (PAAA)
Chevron Corporation (CVX)
Goldman Sachs Etf Tr Ultra Short Bond (GSST)

View all positions for Inscription Capital

Top funds holding Cullinan Oncology

MPM Oncology Impact Management
Lynx1 Capital Management
BVF
BlackRock
Vanguard Group
Deerfield Management Company
Blue Owl Capital Holdings
Kynam Capital Management
Citadel Advisors
OrbiMed Advisors
Rtw Investments
State Street Corporation
Franklin Resources
VR Adviser
Geode Capital Management

View all funds holding Cullinan Oncology